Picture loading failed.

Anti-ITGAV_ITGB3 therapeutic antibody (Pre-made Etaracizumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Etaracizumab, also known as etaratuzumab,[citation needed] MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-195-1mg 1mg 3090
GMP-Bios-ab-195-10mg 10mg 21890
GMP-Bios-ab-195-100mg 100mg 148000
GMP-Bios-ab-195-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-ITGAV_ITGB3 therapeutic antibody (Pre-made Etaracizumab biosimilar,Whole mAb)
INN Name Etaracizumab
TargetITGAV_ITGB3
FormatWhole mAb
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2008
Year Recommended2009
CompaniesApplied Molecular Evolution;MedImmune
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedColorectal cancer;Malignant melanoma;Prostate cancer;Psoriasis;Rheumatoid arthritis
Development Techna